US state NC's biotech investment tops $1B
The US state of North Carolina has invested more than $1.0 billion in its expanding biotechnology enterprise during the past 10 years, and the annual economic impact exceeds $45.0 billion, according to data released at the North Carolina Biotechnology Center.
Norris Tolson, chief executive of the Center, and leaders from the government, education and academic institutions that made those investments spoke at a news conference about the significance of the investment in building a foundation for future growth.
"Smart, steady investment in biotechnology has created a major economic engine in North Carolina," said Mr Tolson. "This technology will help us meet the major global needs of the future - health care, energy and food. But it also brings tangible benefits to North Carolinians in the form of jobs, and the potential is there for many more," he added.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze